Preclinical efficacy of PR115002, a novel sortilin-targeting peptide-drug conjugate, in platinum-resistant ovarian cancer.

Authors: Jingfang Wang, Ying Wang, Zhidong Song, Weikang Ling, Siyu Tong, Hansi Zhang, Cheng Peng

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e17559

Source: Full article

---

Abstract

e17559